News | Denka Company Limited

News

2020

12/21

NewsDenka Published the Integrated Report, Denka Report 2020

12/18

NewsDenka Receives A-Rating in Climate Change and B-Rating in Water Security from CDP 2020

12/17

NewsLatest Epidemiological Study of Chloroprene Monomer Workers in the US

12/16

NewsNotice Regarding a Final and Binding Judgement in Litigation against Singapore Subsidiaries

12/2

NewsDenka Developed a New Heat Dissipating Substrate Enabling Dissimilar Metals to be Joined for xEV ~Introduced during Highly-Functional Material Week~

11/25

NewsDenka Strengthens Environmental Management for Carbon Neutrality by 2050 Presenting Denka’s Original Initiatives at Eco-Pro Online 2020

11/16

NewsConstruction of a New Building for Manufacturing Undiluted Influenza Vaccine has been Completed

11/9

IR InformationFY2020 Second Quarter Financial Results Presentation Summary

IR InformationFY2020 Second Quarter Presentation Materials

IR InformationFY2020 Second Quarter Summary of Consolidated Financial Statements

IR InformationFY2020 Second Quarter Summary of Consolidated Financial Results

NewsDENKA SINGAPORE 40TH ANNIVERSARY 　～INNOVATION THROUGH PROACTIVE INVESTMENT IN NEXT-GENERATION PROJECTS AND HUMAN RESOURCES～

11/5

NewsProduction Capacity increase of Silicon Nitride and Strengthens Functional Ceramics Business

10/30

NewsExpansion of Specimen Types for Influenza Rapid Antigen Test ～For acceleration of simultaneous detection of both influenza and SARS-CoV-2 by expanding and clarifying specimen types for the test～

10/29

NewsDenka Completes Construction of High-Efficiency Gas Turbine Power Generator at Omi Plant ~ Reduction of at least 16,000 tons of CO2 Emissions Annually through Investment of Approximately ¥4 Billion Yen ~

10/9

NewsDenka Releases Advanced Ceramics, "Denka Spherical Magnesia" for 5G and xEV — New thermal solution for strengthening the environmental and energy sectors—

10/2

NewsExpansion of Intended Use and Specimen Types for Denka's COVID 19 Ag Rapid Test kit ~To diminish healthcare and patient burden in SARS-CoV-2 and Influenza antigen testing~

9/23

NewsPhase I Clinical Study to Develop a Norovirus Vaccine Commenced in Belgium

9/14

NewsDenka Expresses Support for Recommendations of the Task Force on Climate-related Financial Disclosures (TCFD) Intensifying Commitment to a Sustainable Society and Information Disclosure

8/31

NewsDenka Decides to Invest Approximately ¥3.7 billion Yen with an Eye toward the Achievement of Greenhouse Gas Emission Targets

8/12

NewsDenka to begin AMED COVID-19 Subsidy Project Conclusion of Agreement to Supply Equipment and Reagents for the Project with Taiwan-Based PlexBio

8/11

NewsApproval for Manufacturing and Marketing of COVID-19 Rapid Antigen Test in Japan ~ QuickNavi™- COVID19 Ag to be distributed to Japanese Medical Institutions starting on August 13 ~

8/7

NewsU.S. EPA review of chloroprene model reaches next step

IR InformationFY2020 First Quarter Financial Results Presentation Summary

IR InformationFY2020 First Quarter Presentation Materials

IR InformationFY2020 First Quarter Summary of Consolidated Financial Results

IR InformationFY2020 First Quarter Summary of Consolidated Financial Statements

7/20

NewsDenka Files Application for Japanese in Vitro Diagnostics Approval of a Simple and Rapid Testing Kit Infection for the COVID-19 Novel Coronavirus

7/17

NewsDenka Formulates Company-Wide Policy for Workstyle Reforms ~ Pursing new workstyles to operate as a company that is truly required by society ~

6/19

NewsDenka’s Views Concerning Some of the Claims about US Subsidiary

6/10

NewsThe Research Proposal for the Multiplex Molecular Diagnosis Systems Included SARS-CoV-2 was Adopted by the Subsidy Project of the Japan Agency for Medical Research and Development (AMED)

6/8

NewsLDEQ confirms 85% emissions reduction achieved, DPE’s completion of voluntary program

6/2

NewsCommencement of Shipment of Diethyl Malonate, Raw Materials for “Avigan”

5/13

IR InformationFY2019 Financial Results Presentation Summary

IR InformationFY2019 Summary of Consolidated Financial Results

IR InformationFY2019 Summary of Consolidated Financial Statements

IR InformationFY2019 Presentation Materials

NewsCommencement of Production of Diethyl Malonate, Raw Materials for “Avigan”

4/13

NewsDenka Affiliate Toyo Styrene to Start a Business for Chemical Recycling of Polystyrene Resins

NewsApplication for Approval of Domestic Manufacture and Sales of Rapid Diagnostic Test Kits for Ebola Virus

4/3

NewsNotice on Joint Development of Limestone Quarry

4/2

NewsNotice Concerning the Supply of Raw Materials for “Avigan” -Denka produces diethyl malonate to prevent the spread of the COVID-19 coronavirus infections -

3/24

NewsKyushu University and Denka Establish Joint Research Department: Comprehensive Collaboration Agreement Signed

NewsNotice Regarding the Status of Development of Simple and Rapid Testing Kits for the COVID-19 Novel Coronavirus Infection

3/19

NewsNotice Regarding Termination of Joint Venture for Manufacturing Polyvinyl Alcohol Resins

3/12

NewsAccelerating Research & Development of a Norovirus Vaccine

3/9

IR InformationAnnouncement of Personnel Changes in Executive Officers

IR InformationRevisions to Consolidated Financial Forecast for the Fiscal Year Ending March 31, 2020

2/14

NewsReview of Chloroprene Monomer Toxicity Assessment Performed by the U.S. Environmental Protection Agency

NewsNotice Regarding Litigation Against US Subsidiary

2/13

NewsNotice Regarding Start of the Development of Simple and Rapid Testing Kits for COVID-19, Novel Coronavirus Infection

CSR InformationCDP Water Security 2019 　Denka was granted a B-rating for its management level

2/7

NewsDenka Establishes Housing Equipment Business Solution Company to Increase the Speed of Specialization

IR InformationFY2019 3rd Quarter Summary of Consolidated Financial Results

IR InformationFY2019 3rd Quarter Summary of Consolidated Financial Statements

1/22

CSR InformationCDP Climate Change Report 2019 　Denka was granted an A- rating for its management level

1/20

NewsDenka Expands Sales of New Functional Resin Denka IP®: IPX Series

1/16

NewsHigh Performance Fluoride Film TEFKA® Adopted for CLT PARK HARUMI Pavilion Supervised by Architect Dr. Kengo Kuma

1/15

NewsDenka Developed New Special High Heat-Resistant Acrylic Elastomer for Automobiles

1/6

NewsNew Year’s Message

Company Overview

Management Plan
"Mission 2030"

Company Branding
and Design

DENKA BIG SWAN
STADIUM

This website uses cookies to ensure that you use this website comfortably.
If you continue to browse this website, you will agree to the use of our cookies.

Our Publications on the Protection of Personal Information